All Referenced Links:
https://linktr.ee/manonthemounjaro
-------- Â
26:22
--------
26:22
SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25
This week, Dave covers massive GLP-1 news out of Connecticut, a new GLP-1 heart study that changes the conversation, and a big OTP event opportunity announcement!
-------- Â
20:20
--------
20:20
BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
https://www.getclaimable.com/otp
Code OTP10 Saves 10%
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
-------- Â
17:34
--------
17:34
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
-------- Â
35:23
--------
35:23
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
https://www.getclaimable.com/otp
Code OTP10 Saves 10%
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
#zepbound #insurance #cvscaremark
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!